Location: Paris, France
CIK: 0001757283 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Jul 22, 2026
Total Value: $206M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVLN | AVALYN PHARMACEUTICALS INC | 929,824 | $30.61M | 14.8% | $32.92 | — | COM SHS | 05348Y105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KMTS | KESTRA MED TECHNOLOGIES LTD | 2,728,679 (+1.2%) | $69.42M (+29.2%) | 33.6% | $25.72 | — | SHS | G52441105 |
| IVA | INVENTIVA SA | 3,633,181 (+99.8%) | $13.73M (+36.1%) | 6.7% | $4.22 | — | ADS | 46124U107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVMN | EVOMMUNE INC | 1,391,990 (-26.6%) | $18.5M (-57.6%) | 9.0% | $18.78 | — | COM SHS | 30054Y107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AGMB | AGOMAB THERAPEUTICS NV | 1,538,702 | $19.97M | 9.7% | $10.49 | — | SPONSORED ADS | 00860C102 |
| ABVX | ABIVAX SA | 78,125 | $10.41M | 5.0% | $134.85 | — | SPONSORED ADS | 00370M103 |
| NYXH | NYXOAH S A | 522,057 | $882K | 0.4% | $4.75 | — | SHS | B6S7WD106 |
| MLYS | MINERALYS THERAPEUTICS INC | 1,591,917 | $42.95M | 20.8% | $40.10 | — | COM | 603170101 |